PhRMA
This article was originally published in The Tan Sheet
Executive Summary
The possibility of working with FDA on dietary supplement regulation/policy was a topic slated for discussion at the annual strategic planning session of the PhRMA board meeting in Chantilly, Va. Nov. 11-12. It appears the trade group sees supplement regulation as a possible common ground on which to build future relations with the agency. Although a handful of PhRMA members market supplement products in the U.S., the majority may look favorably upon an organized effort to squelch supplement claims or increase enforcement actions allowed under DSHEA. Maneuvering could be tricky, however, as one of PhRMA's primary supporters on Capitol Hill - Sen. Orrin Hatch (R-Utah) -also is a staunch advocate of dietary supplements